FIGURE 8. Proportion of the familial excess risk accounted for by known genes or variants in 2014.

FIGURE 8

Proportion of the familial excess risk accounted for by known genes or variants in 2014. ATM, ATM serine/threonine kinase; BRIP1, BRCA1-interacting protein C-terminal helicase 1; CDH1, cadherin 1; CHEK2, checkpoint kinase 2; PALB2, partner and localizer of BRCA2; PTEN, phosphatase and tensin homolog; STK11, serine/threonine kinase 11; ICOG, International Collaborative Oncological Gene-environment Study.

From: Chapter 3, Project 2: assessment of predictive value of new genetic variants

Cover of Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study.
Programme Grants for Applied Research, No. 4.11.
Evans DG, Astley S, Stavrinos P, et al.
Southampton (UK): NIHR Journals Library; 2016 Aug.
Copyright © Queen’s Printer and Controller of HMSO 2016. This work was produced by Evans et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.